Innovating Works
NOVEL: Novel brain health solutions across four focus areas Prevention and care Methods and data Innovat... The NOVEL Postdoctoral Programme pioneers in merging diverse socio-cultural and scientific expertise to forge new brain health solutions, en...
2024-08-05 - 2029-11-30 | Financiado
MES-CoBraD: Multidisciplinary Expert System for the Assessment Management of Complex Brain Disorders ETHNICON METSOVION POLYTECHNION tramitó un H2020: H2020-SC1-BHC-2018-2020 The Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders (MES-CoBraD) is an interdisciplinary project...
2021-01-26 - 2024-09-30 | Financiado
T2EVOLVE: Accelerating Development and Improving Access to CAR and TCR engineered T cell therapy UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT tramitó un H2020: H2020-JTI-IMI2-2019-18-two-stage Immune cells that are empowered by gene-engineering to seek and destroy cancer cells (engineered T cell therapy) constitute a transformative...
2020-11-24 - 2025-12-31 | Financiado
COVIRNA: A diagnostic test to improve surveillance and care of COVID 19 patients LUXEMBOURG INSTITUTE OF HEALTH tramitó un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 Coronavirus disease 2019 (COVID-19) caused by infection with SARS coronavirus 2 (SARS-CoV-2) has reached pandemic proportions with more than...
2020-10-13 - 2023-04-30 | Financiado
Living Evidence: Living Evidence to inform health decisions Development of capacity for the production and use of re... INSTITUT DE RECERCA DE L`HOSPITAL DE LA SANTA CREU I SANT PAU tramitó un H2020: H2020-MSCA-IF-2019 "Further efforts to achieve greater efficiency in allocating healthcare resources are needed in order to guarantee the sustainability of pub...
2020-04-01 - 2022-09-13 | Financiado
ERA4TB: EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS UNIVERSIDAD CARLOS III DE MADRID tramitó un H2020: H2020-JTI-IMI2-2018-15-two-stage The European Regimen Accelerator for Tuberculosis (ERA4TB) has the explicit goal of developing a new combination therapy to treat all forms...
2019-12-12 - 2025-12-31 | Financiado
CARDIATEAM: CARdiomyopathy in type 2 DIAbetes mellitus INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un H2020: H2020-JTI-IMI2-2017-13-two-stage A rapidly evolving epidemic in Type 2 Diabetes (T2DM) is afflicting all ages, sexes and socioeconomic classes which includes serious comorbi...
2019-04-11 - 2026-02-28 | Financiado
TransBioLine: Translational Safety Biomarker Pipeline TransBioLine Enabling development and implementation of n... UNIVERSITAT ZURICH tramitó un H2020: H2020-JTI-IMI2-2017-13-two-stage Qualified biomarkers help to optimize drug development and patient safety, yet for the regulatory acceptance of safety biomarkers substantia...
2019-04-08 - 2025-01-31 | Financiado
COMPAR-EU: Comparing effectiveness of self management interventions in 4 high priority chronic diseases in Euro... FUNDACION AVEDIS DONABEDIAN PARA LA MEJORA DE LA CALIDAD ASISTENCIAL tramitó un H2020: H2020-SC1-2016-2017 COMPAR-EU aims to identify, compare, and rank the most effective and cost-effective self-management interventions (SMIs) for adults in Europ...
2017-11-23 - 2022-12-31 | Financiado
EURE-CART: EURopean Endeavour for Chimeric Antigen Receptor Therapies MOLECULAR MEDICINE SPA tramitó un H2020: H2020-SC1-2016-2017 Cancer is rapidly becoming the most frequent cause of death in EU. Though enormously expensive (several billions EUR/year), currently availa...
2016-12-05 - 2021-06-30 | Financiado
RESSTORE: REgenerative Stem cell therapy for STroke in Europe UNIVERSITE GRENOBLE ALPES tramitó un H2020: H2020-PHC-2014-2015 Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and co...
2015-09-15 - 2020-08-31 | Financiado
m-RESIST: Mobile Therapeutic Attention for Patients with Treatment Resistant Schizophrenia FUNDACIO TICSALUT tramitó un H2020: H2020-PHC-2014-2015 In European Union approximately 5 million people suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, a...
2014-12-12 - 2017-12-31 | Financiado
MASDUHID: Molecular Analysis of Synaptic Dysfunctions Underlying Human Intellectual Disabilities INSTITUT DE RECERCA DE L`HOSPITAL DE LA SANTA CREU I SANT PAU tramitó un FP7: Synapses of the central nervous system are the cellular structures mediating communication between neurons. Mouse mutations studies of synap...
Financiado
DECIDE: Developing and Evaluating Communication strategies to support Informed Decisions and practice based... THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN tramitó un FP7: Objective: To improve the dissemination of evidence-based recommendations by building on the work of the GRADE Working Group to develop and...
Financiado
EVINCI-STUDY: Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Di... CONSIGLIO NAZIONALE DELLE RICERCHE tramitó un FP7: The main purpose of the EVINCI-study is to test the impact of combined anatomo-functional non invasive cardiac imaging for detection and cha...
Financiado
OPEN: Overcome failure to Publish nEgative fiNdings UNIVERSITAETSKLINIKUM FREIBURG tramitó un FP7: Full information about completed and ongoing clinical trials is the indispensable base for decision making about medical therapies and diagn...
Financiado
RECATABI: Regeneration of Cardiac Tissue Assisted by Bioactive Implants INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un FP7: Heart failure is the end-stage of many cardiovascular diseases, but the leading cause is the presence of a large scar due acute to myocardia...
Financiado
DALI: Vitamin D And LIfestyle Intervention for Gestational Diabetes Mellitus GDM Prevention MEDIZINISCHE UNIVERSITAT GRAZ tramitó un FP7: Europe is facing a rapidly growing threat from Type 2 diabetes mellitus (T2D), which is undoubtedly associated with an unhealthy diet and a...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.